NCT05106400View on ClinicalTrials.gov

Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
Healthy
Interventions
DRUG

ZTlido (Lidocaine Topical System) 1.8%

1 ZTlido (Lidocaine Topical System) 1.8% is applied predetermined area on the right or left side of the mid to upper back and worn for 12 hours

DRUG

Salonpas (Lidocaine Patch 4%)

1 Salonpas (Lidocaine Patch 4%) is applied predetermined area on the right or left side of the mid to upper back and worn for 12 hours

DRUG

Aspercreme (Lidocaine Patch 4%)

1 Aspercreme (Lidocaine Patch 4%) is applied predetermined area on the right or left side of the mid to upper back and worn for 12 hours

DRUG

IcyHot (Lidocaine 4% + Menthol 1% Patch)

1 IcyHot (Lidocaine 4% + Menthol 1% Patch) is applied predetermined area on the right or left side of the mid to upper back and worn for 12 hours

Trial Locations (1)

56529

AXIS Clinicals, Dilworth

All Listed Sponsors
lead

Scilex Pharmaceuticals, Inc.

INDUSTRY